20 November 2017
News and Views
Links and Services
This week's issue of the New England Journal of Medicine investigates ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.
No plasma biomarkers are associated with the response of acute graft-versus-host disease to thera
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors